Pfizer Cash on Hand 2010-2024 | PFE

Pfizer cash on hand for the quarter ending December 31, 2024 was $20.477B, a 61.36% increase year-over-year.

  • Pfizer cash on hand for 2024 was $20.477B, a 61.36% increase from 2023.
  • Pfizer cash on hand for 2023 was $12.69B, a 44.18% decline from 2022.
  • Pfizer cash on hand for 2022 was $22.732B, a 26.83% decline from 2021.

Pfizer Cash on Hand 2010-2024 | PFE

  • Pfizer cash on hand for 2024 was $20.477B, a 61.36% increase from 2023.
  • Pfizer cash on hand for 2023 was $12.69B, a 44.18% decline from 2022.
  • Pfizer cash on hand for 2022 was $22.732B, a 26.83% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B